Search research articles
Contact Us
Filters
Showing results (101-110 of 118) with videos related to
Page
of 12
Sort By:
Orphanet Journal of Rare Diseases
|
July 31, 2020
Patients with ACVR1<sup>R206H</sup> mutations have an increased prevalence of cardiac conduction abnormalities on electrocardiogram in a natural history study of Fibrodysplasia Ossificans Progressiva
Samuel Kou, Carmen De Cunto, Geneviève Baujat, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 4, 2025
Linking Baseline PSMA PET-Derived Parameters to Toxicity, Adverse Events, Pain, and Quality of Life in Patients Treated with [<sup>177</sup>Lu]Lu-PSMA-617: A Single-Center Retrospective Study
Vishnu Murthy, Koichiro Kimura, Lela Theus, et al.
Science Translational Medicine
|
November 16, 2018
Sodium-glucose transporter 2 is a diagnostic and therapeutic target for early-stage lung adenocarcinoma
Claudio R Scafoglio, Brendon Villegas, Gihad Abdelhady, et al.
Cell Reports
|
December 8, 2016
Low CD38 Identifies Progenitor-like Inflammation-Associated Luminal Cells that Can Initiate Human Prostate Cancer and Predict Poor Outcome
Xian Liu, Tristan R Grogan, Haley Hieronymus, et al.
Clinical Chemistry
|
April 25, 2018
Characterization of Human Salivary Extracellular RNA by Next-generation Sequencing
Feng Li, Karolina Elżbieta Kaczor-Urbanowicz, Jie Sun, et al.
Cancer & Metabolism
|
September 28, 2018
CD38 is methylated in prostate cancer and regulates extracellular NAD<sup></sup>
Jack Mottahedeh, Michael C Haffner, Tristan R Grogan, et al.
Neurology
|
July 31, 2012
Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial
Teresa Coelho, Luis F Maia, Ana Martins da Silva, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 23, 2019
Tumor Characteristics Associated with Benefit from Pembrolizumab in Advanced Non-Small Cell Lung Cancer
Siwen Hu-Lieskovan, Aaron Lisberg, Jesse M Zaretsky, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 29, 2021
Tumor Sink Effect in <sup>68</sup>Ga-PSMA-11 PET: Myth or Reality?
Andrei Gafita, Hui Wang, Andrew Robertson, et al.
The Lancet. Oncology
|
July 11, 2021
Nomograms to predict outcomes after <sup>177</sup>Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer: an international, multicentre, retrospective study
Andrei Gafita, Jeremie Calais, Tristan R Grogan, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 118) with videos related to
Sort By:
Page
of 12
Orphanet Journal of Rare Diseases
|
July 31, 2020
Patients with ACVR1<sup>R206H</sup> mutations have an increased prevalence of cardiac conduction abnormalities on electrocardiogram in a natural history study of Fibrodysplasia Ossificans Progressiva
Samuel Kou, Carmen De Cunto, Geneviève Baujat, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 4, 2025
Linking Baseline PSMA PET-Derived Parameters to Toxicity, Adverse Events, Pain, and Quality of Life in Patients Treated with [<sup>177</sup>Lu]Lu-PSMA-617: A Single-Center Retrospective Study
Vishnu Murthy, Koichiro Kimura, Lela Theus, et al.
Science Translational Medicine
|
November 16, 2018
Sodium-glucose transporter 2 is a diagnostic and therapeutic target for early-stage lung adenocarcinoma
Claudio R Scafoglio, Brendon Villegas, Gihad Abdelhady, et al.
Cell Reports
|
December 8, 2016
Low CD38 Identifies Progenitor-like Inflammation-Associated Luminal Cells that Can Initiate Human Prostate Cancer and Predict Poor Outcome
Xian Liu, Tristan R Grogan, Haley Hieronymus, et al.
Clinical Chemistry
|
April 25, 2018
Characterization of Human Salivary Extracellular RNA by Next-generation Sequencing
Feng Li, Karolina Elżbieta Kaczor-Urbanowicz, Jie Sun, et al.
Cancer & Metabolism
|
September 28, 2018
CD38 is methylated in prostate cancer and regulates extracellular NAD<sup></sup>
Jack Mottahedeh, Michael C Haffner, Tristan R Grogan, et al.
Neurology
|
July 31, 2012
Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial
Teresa Coelho, Luis F Maia, Ana Martins da Silva, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 23, 2019
Tumor Characteristics Associated with Benefit from Pembrolizumab in Advanced Non-Small Cell Lung Cancer
Siwen Hu-Lieskovan, Aaron Lisberg, Jesse M Zaretsky, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 29, 2021
Tumor Sink Effect in <sup>68</sup>Ga-PSMA-11 PET: Myth or Reality?
Andrei Gafita, Hui Wang, Andrew Robertson, et al.
The Lancet. Oncology
|
July 11, 2021
Nomograms to predict outcomes after <sup>177</sup>Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer: an international, multicentre, retrospective study
Andrei Gafita, Jeremie Calais, Tristan R Grogan, et al.
Page
of 12